GIP Antikörper (AA 113-131)
Kurzübersicht für GIP Antikörper (AA 113-131) (ABIN7139855)
Target
Alle GIP Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 113-131
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Peptide sequence from Human Gastric inhibitory polypeptide protein (113-131AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilution: IHC:1:200-1:500,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- GIP (Gastric Inhibitory Polypeptide (GIP))
-
Andere Bezeichnung
- GIP
-
Hintergrund
-
Background: Potent stimulator of insulin secretion and relatively poor inhibitor of gastric acid secretion.
Aliases: Gastric Inhibitory Peptide antibody, Gastric inhibitory polypeptide antibody, Gastric inhibitory polypeptide precursor antibody, GIP antibody, GIP_HUMAN antibody, Glucose dependent insulinotropic polypeptide antibody, Glucose-dependent insulinotropic polypeptide antibody, Incretin hormone antibody
-
UniProt
- P09681
-
Pathways
- Positive Regulation of Peptide Hormone Secretion, Peptide Hormone Metabolism, Hormone Activity, Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-